Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.34 USD
Change Today +0.11 / 0.90%
Volume 30.8K
LOXO On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joshua H. Bilenker M.D.

Founder, Chief Executive Officer, President and Director, Loxo Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 85 board members in 7 different organizations across 8 different industries.

See Board Relationships
42$5,723,108
As of Fiscal Year 2014

Background*

Dr. Joshua H. Bilenker, also known as Josh MD, is an Operating Partner at Aisling Capital LLC. He previously served as a Principal at the firm. Dr. Bilenker has been the Chief Executive Officer and President of Loxo Oncology, Inc., which he founded May 2013. He served as the Chief Financial Officer and Principal Accounting Officer of Loxo Oncology, Inc. Previously, he served as a Medical Officer in the Office of Oncology Drug Products at the United States Food and Drug ...

Read Full Background

Corporate Headquarters*

One Landmark Square
Stamford, Connecticut 06901

United States

Phone: 203-653-3880
Fax: --

Board Members Memberships*

Director
Director
Director
2008-Present
Director
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2011-2015
Former Director and Member of Audit Committee
2013-Present
Founder, Chief Executive Officer, President and Director

Education*

BA
Princeton University
MD
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

Salary$350,000
Total Annual Compensation$350,000

Stock Options*

Exercisable Options333,662
Unexercisable Options413,782
Total Number of Options747,444

Total Compensation*

Total Annual Cash Compensation$350,000
Total Short Term Compensation$350,000
Total Calculated Compensation$5,723,108
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LOXO:US $12.34 USD +0.11

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOXO ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.